Single cell sequencing techniques in early and late breast cancer

The future of PI3K/AKT/mTOR inhibitors in breast cancer

Multitarget FISH testing in lung cancer

Mesothelioma and the tumour suppressor gene, NF2

Next generation sequencing in oncology

Extracellular matrix proteins of stem cell niches promote breast cancer metastasis

Update on the METABRIC consortium 2000 Breast Cancer Study

The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence

Implementation of individualised treatment and the WINTHER trial

Importance of personalised medicine and the WIN Consortium